z-logo
open-access-imgOpen Access
Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients With Moderate Traumatic Brain Injury
Author(s) -
Maria Gabriela Figueiró Longo,
Can Ozan Tan,
SukTak Chan,
Jonathan Welt,
Arman Avesta,
Eva Ratai,
Nathaniel D. Mercaldo,
Anastasia Yendiki,
Jacqueline Namati,
Isabel ChicoCalero,
Blair A. Parry,
Lynn A. Drake,
R.B. Anderson,
Terry M. Rauch,
Ramon DiazArrastia,
Michael H. Lev,
Jarone Lee,
Michael R. Hamblin,
Benjamin J. Vakoc,
Rajiv Gupta
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.17337
Subject(s) - traumatic brain injury , medicine , rivermead post concussion symptoms questionnaire , randomized controlled trial , physical therapy , neurocognitive , anesthesia , cognition , psychiatry
Key Points Question Is near-infrared low-level light therapy (LLLT) feasible and safe after moderate traumatic brain injury, and does LLLT affect the brain and exhibit neuroreactivity? Findings In this randomized clinical trial including 68 patients with moderate traumatic brain injury who were randomized to receive LLLT or sham therapy, 28 patients completed at least 1 LLLT session without any reported adverse events. In the late subacute stage, there were statistically significant differences in the magnetic resonance imaging–derived diffusion parameters of the white matter tracts between the sham- and light-treated groups, demonstrating neuroreactivity of LLLT. Meaning The results of this clinical trial show that transcranial LLLT is feasible, safe, and affects the brain in a measurable manner.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom